MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Teligent Company Profile (NASDAQ:TLGT)

Consensus Ratings for Teligent (NASDAQ:TLGT) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $10.00 (48.37% upside)

Analysts' Ratings History for Teligent (NASDAQ:TLGT)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Raymond JamesInitiated CoverageStrong-Buy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Deutsche BankLower Price TargetHold$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalBoost Price TargetNeutral -> Buy$7.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Teligent (NASDAQ:TLGT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/28/2016Q116($0.03)$0.02$14.33 million$15.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.02)($0.02)$11.69 million$13.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Teligent (NASDAQ:TLGT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.01)($0.01)($0.01)
Q4 20161$0.02$0.02$0.02
(Data provided by Zacks Investment Research)
Dividend History for Teligent (NASDAQ:TLGT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Teligent (NASDAQ:TLGT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/11/2016James C GaleDirectorBuy15,000$4.91$73,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Jason Grenfell-GardnerCEOBuy10,500$4.82$50,610.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Teligent (NASDAQ:TLGT)
DateHeadline
06/23/16 07:34 PMBiggest Movers in Manufacturing Stocks Now - CVV GNCA TANH MLSS - Investorplace.com
06/23/16 07:34 PMTeligent Inc (NASDAQ:TLGT) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 04:51 AMCoverage initiated on Teligent by Raymond James -
06/21/16 07:39 AMTeligent, Inc. To Present At JMP Securities Life Sciences Conference On June 21, 2016 - [at noodls] - BUENA, N.J., June 21, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the JMP Securities Life Sciences Conference. ...
06/17/16 09:28 AMAllergan Glaucoma Gel Stent Filing Accepted for FDA Review
06/09/16 09:54 AMTeligent, Inc. (NASDAQ:TLGT) Fundamental Star Rating Report - CML News
05/27/16 03:06 PMTELIGENT, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu -
05/24/16 01:58 PMBull Vs. Bear: Teligent, Inc. -
05/19/16 07:02 PMETF’s with exposure to Teligent, Inc. : May 20, 2016 -
05/17/16 10:53 AMTeligent, Inc. :TLGT-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 10:31 AMTeligent: FDA Approves Triamcinolone Acetonide Ointment, Launch Planned For Q2 - (RTTNews.com) - Teligent, Inc. ( TLGT), a specialty generic pharmaceutical company, announced Monday that it has received approval of its abbreviated new drug application or ANDA from the U.S. Food and Drug Administration or FDA of Triamcinolone Acetonide ...
05/16/16 07:32 AMTeligent, Inc. Announces FDA Approval Of Triamcinolone Acetonide Ointment USP, 0.1% - [at noodls] - BUENA, N.J., May 16, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that it has received approval of the Company's abbreviated ...
05/16/16 07:08 AM8:08 am Teligent confirms approval of ANDA from FDA of Triamcinolone Acetonide Ointment USP, 0.1% -
05/12/16 10:17 AMPerformance Recap and Target Perspective on Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialIn the latest trading session, shares of Teligent Inc (NASDAQ:TLGT) moved -1.46%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/10/16 05:16 PMTELIGENT, INC. Files SEC form 10-Q, Quarterly Report -
05/10/16 07:28 AMTeligent, Inc. To Present At Bank of America Merrill Lynch Annual Health Care Conference On May 10, 2016 - [at noodls] - BUENA, N.J., May 10, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the Bank of America Merrill Lynch 2016 Health ...
05/06/16 10:36 AMAverage Analyst Rating for Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Average Analyst Rating for Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2 on Teligent Inc (NASDAQ:TLGT) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/03/16 10:02 AMSmall Cap Gainers: Teligent (NASDAQ:TLGT), Newpark Resources Inc. (NYSE:NR), TimkenSteel (NYSE:TMST), The ... - KC Register - Small Cap Gainers: Teligent (NASDAQ:TLGT), Newpark Resources Inc. (NYSE:NR), TimkenSteel (NYSE:TMST), The ...KC RegisterTeligent, Inc. (NASDAQ:TLGT) announced its financial results for the first quarter ended March 31, 2016. Revenue from the Teligent portfolio of injectable and topical products was $9.2 million for the quarter, a 13.5% increase over the same quarter ...and more »
05/03/16 07:45 AMTeligent (TLGT) Worth a Look: Stock Up 6.3% in Session -
05/03/16 07:10 AMTeligent, Inc. To Present At Deutsche Bank 41st Annual Health Care Conference On May 4, 2016 - [at noodls] - BUENA, N.J., May 3, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jerseybased specialty generic pharmaceutical company, will be presenting at the Deutsche Bank 41 Annual Health Care Conference. ...
05/02/16 10:51 AMActive Stocks Rising, May 2 – ENVA, EHTH, TLGT, PCMI, CIR, SCSS, MNST, PNK, SKYW, BGS - Teligent Inc (New) (TLGT) traded at $6.03 + 0.96 (18.93 percent). The company is +19.70 percent during the last four weeks, -32.25 percent year to date, and +8.65 percent in the past four quarters. PCM Inc. (PCMI) traded at $9.45 + 1.20 (14.55 percent).
04/28/16 05:13 PMTeligent reports 1Q loss -
04/28/16 03:26 PMTeligent, Inc. Announces First Quarter 2016 Results - [at noodls] - BUENA, N.J., April 28, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended ...
04/28/16 10:12 AMShare Performance and Target Price Review Teligent Inc (NASDAQ:TLGT) - B.O.D.Y Confidential - Share Performance and Target Price Review Teligent Inc (NASDAQ:TLGT)B.O.D.Y ConfidentialDuring the most recent trading session, shares of Teligent Inc (NASDAQ:TLGT) ended up with a move of -3.35%. Sell-side analysts have given a consensus target price of $9.00 on company shares. Target price projections may differ greatly from one analyst ...and more »
04/28/16 10:11 AMTeligent Inc (NASDAQ:TLGT) Share Rating Recap - B.O.D.Y Confidential - Teligent Inc (NASDAQ:TLGT) Share Rating RecapB.O.D.Y ConfidentialShares of Teligent Inc (NASDAQ:TLGT) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/27/16 10:31 AMTeligent, Inc. (NASDAQ:TLGT) To Report Earnings Tomorrow - Share Trading News - Teligent, Inc. (NASDAQ:TLGT) To Report Earnings TomorrowShare Trading NewsThey expect $-0.03 EPS, down 100% or $0.03 from last year's $0 per share. At the moment 5 analysts are watching Teligent, Inc. (NASDAQ:TLGT), 0 rate it “Buy”, 2 “Outperform”, 3 “Underperform”, 0 “Sell”, while 0 “Hold”. Looking forward, for the quarter ...
04/26/16 10:33 AMTeligent Inc (NASDAQ:TLGT) Wall Street Rating in Focus - News Tribune - Teligent Inc (NASDAQ:TLGT) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 3 equity research firms that cover shares of Teligent Inc (NASDAQ:TLGT). Sell ...and more »
04/26/16 10:33 AMTeligent Inc (NASDAQ:TLGT) Share Rating Recap - The Post - Teligent Inc (NASDAQ:TLGT) Share Rating RecapThe PostShares of Teligent Inc (NASDAQ:TLGT) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
04/25/16 08:30 AMThe Zacks Analyst Blog Highlights: Teligent, BHP Billiton, LinkedIn, Zayo Group Holdings and Opko Health -
04/19/16 10:04 AMTeligent Inc (NASDAQ:TLGT): Where are Shares Headed? - News Tribune - Teligent Inc (NASDAQ:TLGT): Where are Shares Headed?News TribuneResearch analysts covering Teligent Inc (NASDAQ:TLGT) shares have provided price target projections on the popular stock. They project that the shares are expected to reach $9 within the upcoming year. This consensus number they've arrived at is ...and more »
04/15/16 10:22 AMView on Ratings Teligent Inc (NASDAQ:TLGT) - Business Standard Tribune - View on Ratings Teligent Inc (NASDAQ:TLGT)Business Standard TribuneUsing a scale from 1 to 5, Teligent Inc (NASDAQ:TLGT) has a rating of 2.2 on the stock. A score of 1 or 2 indicates a Buy rating, and a score of 4 or 5 indicates a Sell rating. A 3 would indicate a Hold. This consensus number is made up of covering ...Teligent Incorporated (NASDAQ:TLGT) Shorts Decreased by 2.54% After Short CoveringFranklin Independentall 2 news articles »
04/14/16 10:07 AMTeligent, Inc. To Hold Conference Call For 1st Quarter 2016 Results - PR Newswire (press release) - Teligent, Inc. To Hold Conference Call For 1st Quarter 2016 ResultsPR Newswire (press release)BUENA, N.J., April 14, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Thursday, April 28, 2016 to discuss the 1st ...and more »
04/14/16 07:29 AMTeligent, Inc. To Hold Conference Call For 1st Quarter 2016 Results - [at noodls] - BUENA, N.J., April 14, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ETon ...
04/13/16 10:04 AMTeligent Inc (NASDAQ:TLGT) Analyst Recommendation Outlook - Clinton Financial - Teligent Inc (NASDAQ:TLGT) Analyst Recommendation OutlookClinton FinancialCovering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 4 analysts providing ratings for Teligent Inc (NASDAQ:TLGT). 2 have given the stock a “Strong Buy”, 0 rate it a “Buy”, 3 are ...and more »
04/12/16 09:44 AMTeligent Inc (NASDAQ:TLGT): Quick Look at Earnings - News Tribune - Teligent Inc (NASDAQ:TLGT): Quick Look at EarningsNews TribuneWhen Teligent Inc (NASDAQ:TLGT) issues their next quarterly report on or near 2016-04-26, Wall Street analysts are predicting they will report earnings per share of $-0.03. This consensus EPS number is provided by Zacks Research, which might differ ...and more »
04/09/16 09:40 AMEarnings View for Teligent Inc (NASDAQ:TLGT) - RiversideGazette.com - Earnings View for Teligent Inc (NASDAQ:TLGT)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $-0.03 on shares of Teligent Inc (NASDAQ:TLGT). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around 2016-04-26 for ...Will Teligent Inc Short Squeeze Soon?Franklin Independentall 2 news articles »
04/08/16 09:51 AMAnalyst Ratings Check Teligent Inc (NASDAQ:TLGT) - Business Standard Tribune - Analyst Ratings Check Teligent Inc (NASDAQ:TLGT)Business Standard TribuneCovering sell-side analysts have an average rating of 2.2 on shares of Teligent Inc (NASDAQ:TLGT). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on a 1 to 5 scale. A 1 or 2 ...and more »
04/06/16 09:50 AMShould Investors Buy Teligent Inc (NASDAQ:TLGT)? - Clinton Financial - Should Investors Buy Teligent Inc (NASDAQ:TLGT)?Clinton FinancialThey issue Buy, Sell and Hold recommendations as well as earnings estimates and guidance. Out of the 4 analysts covering shares of Teligent Inc (NASDAQ:TLGT), 2 rate it a “Strong Buy”, 0 rate it a “Buy”, 3 are advising to Hold the shares and 0 are ...and more »
04/05/16 09:31 AMAnalysts Anticipate SMLF Will Reach $33 - ... SMLF's underlying holdings with notable upside to their analyst target prices are AgroFresh Solutions Inc (AGFS), Teligent Inc (TLGT), and AAC Holdings Inc (AAC). Although AGFS has traded at a recent price of $6.02/share, the average analyst target is ...
04/03/16 09:30 AMKopp Investment Advisors Lowers stake in Teligent Inc (TLGT) - Street Edition - Kopp Investment Advisors Lowers stake in Teligent Inc (TLGT)Street EditionTeligent Inc (TLGT) : Kopp Investment Advisors reduced its stake in Teligent Inc by 0.92% during the Q4 period. The investment management company now holds a total of 1,913,545 shares of Teligent Inc which is valued at $8.8 Million after selling 17,775 ...and more »
04/02/16 09:37 AMEarnings Outlook on Teligent Inc (NASDAQ:TLGT) - RiversideGazette.com - Earnings Outlook on Teligent Inc (NASDAQ:TLGT)RiversideGazette.comAnalysts and investors will be looking forward to the next earnings release from Teligent Inc (NASDAQ:TLGT) which is scheduled to be on or around 2016-04-26 for the period ending 2016-03-31. Covering sell-side analysts have a current quarter earnings ...and more »
04/01/16 09:39 AMAverage Rating Watch Teligent Inc (NASDAQ:TLGT) - Business Standard Tribune - Average Rating Watch Teligent Inc (NASDAQ:TLGT)Business Standard TribuneStreet analysts that cover Teligent Inc (NASDAQ:TLGT) presently have an average broker rating of 2.2 on the stock. This average rating comes from Zacks Research compiling polled analyst ratings taken into consideration. The average rating falls on a ...and more »
03/31/16 04:28 PMTELIGENT, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and -
03/31/16 08:55 AMTeligent, Inc. Appoints Dr. Carole Ben-Maimon To Board Of Directors - [at noodls] - BUENA, N.J., March 31, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Dr. Carole Ben-Maimonto its Board ...
03/30/16 09:26 AMFirst Light Asset Management Lowers stake in Teligent Inc (TLGT) - Everything HUDSON - MicroCap MagazineFirst Light Asset Management Lowers stake in Teligent Inc (TLGT)Everything HUDSONTeligent Inc (TLGT) : First Light Asset Management reduced its stake in Teligent Inc by 1.25% during the Q4 period. The investment management company now holds a total of 998,610 shares of Teligent Inc which is valued at $4.6 Million after selling 12 ...Teligent Inc (NASDAQ:TLGT) Given Consensus Rating of "Buy" by BrokeragesThe Vista VoiceTeligent Inc (NASDAQ:TLGT) Given Consensus Rating of “Buy” by BrokeragesMicroCap MagazineWhat's in Teligent Inc After Today's Huge Decline?Business Standard Tribuneall 4 news articles »
03/26/16 09:42 AMLooking Ahead to Earnings for Teligent Inc (NASDAQ:TLGT) - RiversideGazette.com - Looking Ahead to Earnings for Teligent Inc (NASDAQ:TLGT)RiversideGazette.comInvestors and analysts will be looking ahead to Teligent Inc (NASDAQ:TLGT)'s next earnings report which is slated to be released sometime on or around 2016-04-26 for the period ending on 2016-03-31. Street analysts have a consensus EPS projection of ...and more »
03/25/16 09:32 AMRating Update for Teligent Inc (NASDAQ:TLGT) - Business Standard Tribune - Rating Update for Teligent Inc (NASDAQ:TLGT)Business Standard TribuneSell-side analysts currently have an average broker rating of 2.2 on shares of Teligent Inc (NASDAQ:TLGT). This rating averages all the recommendations from analysts that are taken into consideration by Zacks Research. Using a standardized scale from 1 ...and more »
03/21/16 07:18 AMTeligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) - [at noodls] - BUENA, N.J., March 21, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has launched Cefotan® (cefotetan for injection). ...
03/19/16 08:53 AMRevenue Update on Teligent Inc(NASDAQ:TLGT) - Street Edition - Revenue Update on Teligent Inc(NASDAQ:TLGT)Street EditionTeligent Inc(NASDAQ:TLGT) announced the earnings results for Fiscal Year 2015 and Q4. The results came in during After-hours on Mar 9, 2016. Earnings per share were $-0.02. Teligent Inc. formerly IGI Laboratories Inc. is a specialty generic ...
03/17/16 09:24 AMTeligent, Inc. (TLGT) Files Form 4 Insider Buying : James C Gale Buys 15000 Shares - Everything HUDSON - Teligent, Inc. (TLGT) Files Form 4 Insider Buying : James C Gale Buys 15000 SharesEverything HUDSONTeligent, Inc. (TLGT): James C Gale , director 10% owner of Teligent, Inc. purchased 15,000 shares on Mar 11, 2016. The Insider buying transaction was disclosed on Mar 14, 2016 to the Securities and Exchange Commission. The shares were purchased at ...
About Teligent

Teligent logoTeligent, Inc., formerly IGI Laboratories, Inc., is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It has two platforms: developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its current contract manufacturing and formulation services business. Its pipeline includes over 30 Abbreviated New Drug Applications filed with the United States Food and Drug Administration for additional pharmaceutical products. It holds additional over 40 product candidates at various stages of its development pipeline, 10 of which are on stability testing.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TLGT
  • CUSIP:
Key Metrics:
  • Previous Close: $6.74
  • 50 Day Moving Average: $5.96
  • 200 Day Moving Average: $6.31
  • P/E Ratio: N/A
  • P/E Growth: 44.93
  • Market Cap: $357.62M
  • Current Quarter EPS Consensus Estimate: $0.01 EPS
Additional Links:
Teligent (NASDAQ:TLGT) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha